• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

Applications of ALBA Synchrotron for the pharmaceutical industry
20 June 2022

Applications of ALBA Synchrotron for the pharmaceutical industry

As you know, in NANOMOL TECHNOLOGIES we are committed to the constant #training of our #team to keep #growing in our #sector.

This Monday, Oscar and Lidia attended the #conference, organized by ALBA Synchrotron together with Biocat, BioRegion of Catalonia under the slogan: “Applications of ALBA Synchrotron for the #pharmaceutical #industry.”

This has allowed us to learn about the applications of #synchrotron light, which includes critical stages for the sector such as the design of new #drugs or the #characterization of active ingredients in the final #formulation, among others. In addition, it was very interesting to #learn about the different success #cases presented by relevant #companies such as Eli Lilly and Company, Crysforma and Enantia.

The #networking lunch at the end of the training allowed us to ask more detailed questions to the ALBA Synchrotron team and to talk with other #participants.

Let’s continue!

Related
news

Stable nanovesicles formed by intrinsically planar bilayers 15 December 2022

Stable nanovesicles formed by intrinsically planar bilayers

Nanomol Technologies will attend the 7th edition of FarmaForum 27 October 2021

Nanomol Technologies will attend the 7th edition of FarmaForum

Our paper has been selected for the cover image of the June 2021 issue of Advanced Therapeutics! 21 June 2021

Our paper has been selected for the cover image of the June 2021 issue of Advanced Therapeutics!

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2026

Nanomol Technologies S.L.

Site by Suki